tramadol has been researched along with Diabetes Mellitus, Type 1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cano-Megías, M; Cortés-Berdonces, M; Guisado Vasco, P; Llanero-Luque, M | 1 |
Boonchaya-Anant, P; Ganokroj, P | 1 |
de Moraes, NV; Lanchote, VL; Lauretti, GR | 1 |
Authier, F; Dautriche, A; Duhoux, F; Grandvuillemin, A; Jolimoy, G; Sgro, C | 1 |
4 other study(ies) available for tramadol and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Treatment-induced diabetes neuropathy: description of singular clinical signs to reach a prompt diagnosis.
Topics: Diabetes Mellitus, Type 1; Diabetic Neuropathies; Dibenzazepines; Drug Therapy, Combination; Electromyography; Female; Foot; Gabapentin; Humans; Insulin; Neuralgia; Tramadol; Treatment Outcome; Walk Test; Young Adult | 2020 |
Diabetic muscle infarction: rare complication with a distinct clinical manifestation.
Topics: Analgesics, Opioid; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Humans; Hypoglycemic Agents; Infarction; Insulin; Magnetic Resonance Imaging; Muscle, Skeletal; Peripheral Nervous System Diseases; Tramadol; Treatment Outcome; Ultrasonography; Young Adult | 2019 |
Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers.
Topics: Adult; Analgesics, Opioid; Area Under Curve; Blood Glucose; Cytochrome P-450 CYP2D6; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neuralgia; Phenotype; Stereoisomerism; Tramadol | 2014 |
[Tramadol-induced hypoglycemia. 2 cases].
Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Diabetes Mellitus, Type 1; Female; Humans; Hypoglycemia; Time Factors; Tramadol | 2006 |